Nostrum Laboratories Sucralfate Tablets, USP 1 gram recall — FDA D-0547-2025
CGMP Deviations: The recalling firm filed for Chapter 11 in September 2024. As a result, it cannot monitor the quality program and hence cannot assure that products meet the identity,…